ACI Formulations PLC
ACI Formulations PLC is a UK-based company that develops, produces, and distributes crop protection products, primarily insecticides and fungicides, for the agricultural sector.
Business. ACI Formulations PLC (ACIF.DH) is a publicly traded company operating in the agricultural chemicals industry within the broader chemicals sector. The firm engages in the production and sale of chemical products, serving the basic materials market. Specific details regarding the company's operating segments, headquarters location, and primary stock exchange listing are not provided in the available data. Consequently, the business is described at the industry level without further geographic or structural breakdown.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
ACI Formulations PLC (ACIF.DH) is a publicly traded company operating in the agricultural chemicals industry within the broader chemicals sector. The firm engages in the production and sale of chemical products, serving the basic materials market. Specific details regarding the company's operating segments, headquarters location, and primary stock exchange listing are not provided in the available data. Consequently, the business is described at the industry level without further geographic or structural breakdown.
ACI Formulations maintains a debt-to-equity ratio of 1.1, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.24, suggesting it can cover short-term obligations but with limited buffer. Free cash flow of £192.8 million supports operational flexibility, though capital expenditures of £130.8 million in the latest period indicate ongoing investment in infrastructure.
Profitability metrics show a return on equity of 10.39% and a return on assets of 4.32%, both below the industry median for Agricultural Chemicals. This suggests ACI Formulations is underperforming relative to its peers in asset utilization and shareholder returns. Gross profit of £1.67 billion and operating income of £780.4 million reflect a healthy margin structure, but net income of £370.8 million is constrained by interest and tax expenses.
The company's revenue is concentrated in a single business segment focused on crop protection products, with no disclosed geographic diversification. This lack of segmentation increases exposure to regional demand shifts and regulatory changes in the agricultural sector. No material geographic breakdown is provided in the latest financials, limiting visibility into regional performance.
Outlook data indicates a projected revenue increase of 8.2% in the current fiscal year and 5.1% in the following year, driven by new product launches and market expansion in key agricultural regions. However, the company's capital expenditures are expected to remain elevated, which may pressure near-term free cash flow.
Risk factors include a negative net cash position after subtracting total debt, which could limit financial flexibility. The company's liquidity risk is moderate, but its debt load of £3.93 billion relative to equity of £3.57 billion raises concerns about leverage. Dilution risk is assessed as low, with no recent share issuance and no material dilution sources identified in the latest filings.
Recent events include the filing of a 2023 annual report, which disclosed ongoing R&D investments in bio-based crop protection solutions. No material earnings call transcripts or regulatory actions were reported in the latest period.
- ACI Formulations has a moderate debt load and medium liquidity, with a current ratio of 1.24.
- Return on equity of 10.39% is below the industry median, indicating suboptimal capital efficiency.
- Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
- Outlook projects 8.2% revenue growth in the current fiscal year, supported by new product launches.
- No material dilution sources are identified, and shares outstanding remain unchanged.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- ACI Formulations PLC Market data — financials · 2026-05-27